Use of hormonal contraceptives and risk of HIV-1 transmission

The Lancet Infectious Diseases

Volumn 12, Issue 7, 2012, Pages 509-

  Beksinska, Mags E ^a,b   Smit, Jennifer ^a   Kleinschmidt, Immo ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ENANTATE; ORAL CONTRACEPTIVE AGENT;

HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; LETTER; PRIORITY JOURNAL; SOUTH AFRICA; VIRUS TRANSMISSION; DISEASE TRANSMISSION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NOTE;

CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE;

EID: 84862727697     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70109-3     Document Type: Letter

References (5)

1. Heffron R, Donnell D, Rees H, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012, 12:19-26.
2. South Africa Demographic and Health Survey 2003. 2007 Department of Health, Medical Research CouncilMedical Research Council, (accessed May 30, 2012). http://www.measuredhs.com/pubs/pdf/FR206/FR206.pdf.
3. Kleinschmidt I, Rees H, Delany S, et al. Injectable progestin contraceptive use and risk of HIV infection in a South Africa family planning cohort. Contraception 2007, 75:461-467.
4. Hapgood JP, Koubovec D, Louw A, Africander D Not all progestins are the same: implications for usage. Trends Pharmacol Sci 2004, 25:554-557.
5. Fraser IS, Weisberg E A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. Med J Aust 1981, 1(suppl 1):3-19.